Clinical Trial

Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease

Study acronym: SmIle
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 31, 2025 (before its estimated February 2025 completion). Its status may not reflect the trial's current state.
Summary
Observational cross-sectional study in PD patients and healthy controls (HC) using an investigational medical device consisting of a passive small intestine microbiome aspiration (SIMBA) system (capsule) that is ingested orally and recovered together with the stools (home recovery) together with blood sampling (during the onsite visit).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-08-15; most recent amendment 2025-01-30.
Status change: Recruiting → Active, Not Recruiting 2025-01-30
Status change: Not Yet Recruiting → Recruiting 2024-02-02
Trial Details
NCT Number NCT06003608
Lead Sponsor Nimble Science Ltd.
Collaborators: MRM Health NV
Conditions Parkinson Disease
Enrollment 100 participants
Start Date 2024-02-19
Primary Completion 2025-02 (estimated)
Study Completion 2025-02 (estimated)
Updated on ClinicalTrials.gov 2025-01-31